Wu, H., Yeh, S., & Chen, H. Brentuximab Vedotin Treatment for Primary Refractory Hodgkin Lymphoma. Wiley.
Chicago Style (17th ed.) CitationWu, Hung-Bo, Shyh-An Yeh, and Huei-Yung Chen. Brentuximab Vedotin Treatment for Primary Refractory Hodgkin Lymphoma. Wiley.
MLA (9th ed.) CitationWu, Hung-Bo, et al. Brentuximab Vedotin Treatment for Primary Refractory Hodgkin Lymphoma. Wiley.
Warning: These citations may not always be 100% accurate.